RFK Jr. and Elon Musk want to ban pharma ads. They wouldn’t be the first to try

Sign up for free to read a limited number of articles each month.

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

FDA approves Novartis’ Cosentyx

Novartis’ Cosentyx hinders interleukin-17A, a cytokine associated with inflammation in HS patients. Credit: Novartis AG. The US Food and Drug Administration (FDA) has granted approval for Novartis’

Read More »